A novel bispecific checkpoint inhibitor antibody to preferentially block PD-1 and LAG-3 on dysfunctional TILs whilst sparing Treg activationLaura Codarri Deak,Patrick Weber,Stefan Seeber,Mario Perro,Xavier Miot, Heidi Poulet,Iryna Dekhtiarenko, Matthias Futh,Henry Kao,Christine McIntyre,Francesca Michielin,Christian Klein,Pablo Umana,Lin-Chi Chen, Christoph Markert, Merlind MuckeJOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）引用 1|浏览26暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
